1997PubMedRequires access

[Drugs active against herpesviruses].

Fillet Am

Open publisher page 0 citations

Abstract

Drugs active against herpesvirus are undergoing rapid development. Acyclovir is the antiviral drug of choice for treatment of herpes simplex virus (HSV) infections and the varicella and zona virus (VZV) because of its efficacy and lack of toxicity. Valaciclovir, precursor of acyclovir, allows reducing the daily intake to 2 doses for HSV infections and to 3 doses for VZV. For cytomegalovirus infections and HSV that are resistant to acyclovir in immunodepressed patients, ganciclovir and foscarnet are available and effective but can involve respectively haematologic and renal toxicity. Penciclovir, the active form of famciclovir, is a new antiviral drug indicated in the treatment of zona.

About this research paper

What this paper is about

Drugs active against herpesvirus are undergoing rapid development. Acyclovir is the antiviral drug of choice for treatment of herpes simplex virus (HSV) infections and the varicella and zona virus (VZV) because of its efficacy and lack of toxicity. Valaciclovir, precursor of acyclovir, allows reducing the daily intake to 2 doses for HSV infections and to 3 doses for VZV. For cytomegalovirus infections and HSV that are resistant to acyclovir in immunodepressed patients, ganciclovir and foscarnet are available and effective but can involve respectively haematologic and renal toxicity. Penciclovir, the active form of famciclovir, is a new antiviral drug indicated in the treatment of zona.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Drugs active against herpesvirus are undergoing rapid development. Acyclovir is the antiviral drug of choice for treatment of herpes simplex virus (HSV) infections and the varicella and zona virus (VZV) because of its efficacy and lack of toxicity. Valaciclovir, precursor of acyclovir, allows reducing the daily intake to 2 doses for HSV infections and to 3 doses for VZV. For cytomegalovirus infections and HSV that are resistant to acyclovir in immunodepressed patients, ganciclovir and foscarnet are available and effective but can involve respectively haematologic and renal toxicity. Penciclovir, the active form of famciclovir, is a new antiviral drug indicated in the treatment of zona.

Key concepts: Penciclovir, Valaciclovir, Famciclovir, Foscarnet, Ganciclovir, Herpes simplex virus, Varicella zoster virus, Herpesviridae

Related papers

Back to paper searchBrowse research topicsOriginal source
[Drugs active against herpesviruses]. — Research Paper | ScholarLens